Generic Sucralfate Oral Suspension

About Abon Pharmaceuticals

Abon Pharmaceuticals is a private, commercial-stage specialty pharma company targeting the complex generics market. Its strategy centers on developing difficult-to-formulate products, such as suspensions and injectables, where scientific expertise creates a competitive moat. The company recently achieved a significant milestone with FDA approval for its generic version of Carafate® Oral Suspension, demonstrating execution capability in a market with substantial sales potential. Abon's integrated R&D capabilities, from preformulation to pharmacokinetics, position it to build a pipeline of high-value generic and proprietary products.

Therapeutic Areas